Sorin Group Opens New International Training Center for Healthcare Professionals

Sorin Group, (MIL:SRN) (Reuters Code: SORN.MI), a global medical company and a leader in the treatment of cardiovascular diseases, announced today the opening of its Advanced Center for Continuous Education on Scientific Solutions - ACCESS - training center in Clamart (Paris). This state-of-the-art training center conducts quality training through lectures, peer-to-peer education and hands-on experience workshops.

ACCESS offers a comprehensive series of education modules for heart rhythm specialists, electrophysiology fellows, cardiologists and allied healthcare professionals. The training courses are delivered by internationally recognized experts who have a passion to share their knowledge. In this unique multicultural environment, members benefit from exchanging best in-clinic practices and enjoy productive, enriching peer-to-peer interactions.

As an educational partner of the European Heart Rhythm Association (EHRA), Sorin pays special attention to the quality of ACCESS educational and training contents.

"With all the new developments in the medical device industry, it is important that Sorin partners with dedicated medical professionals to help drive continuous learning,” said Hein Heidbüchel, MD PhD, University Hospital Gasthuisberg, Leuven, Belgium and Chair of the EHRA (European Heart Rhythm Association) Educational Committee.

"ACCESS will not only host our CRM customers, but all cardiac health professionals across our three therapeutic areas will benefit from its advanced facilities," commented Stefano Di Lullo, Sorin Group, President of the CRM Business Unit. "The opening of ACCESS is another testimonial of our commitment to provide best in class clinical and technical training, and to assist medical professionals in their pursuit of excellence in patient care."

About Sorin Group
Sorin Group (www.sorin.com) is a global, medical device company and a leader in the treatment of cardiovascular diseases. The Company develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders. With 3,700 employees worldwide, Sorin Group focuses on three major therapeutic areas: cardiopulmonary bypass (extracorporeal circulation and autotransfusion systems), cardiac rhythm management, and heart valve repair and replacement. Every year, over one million patients are treated with Sorin Group devices in more than 80 countries.

For more information, please visit www.sorin.com